Use of Air Purifiers to Improve Respiratory Health in Children
NCT ID: NCT05817357
Last Updated: 2024-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2023-05-02
2024-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Does installing an air purifier in the homes of children and young people with asthma improve their asthma outcomes
* Is the use of an air purifier in the home acceptable to children and young people and their families?
Children and young people with asthma attending our clinic will be selected at random to be invited to take part. For those that take part, an air purifier (Rensair Ltd. - Rensair Compact) will be installed in their home for a one-year period. Data will be collected on numbers of asthma attacks, rescue oral steroids, quality of life, symptoms, lung function at the beginning and at three-monthly intervals throughout the study period. The acceptability to children and young people and their families taking part in this study of using an air purifier in their home will also be assessed.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main questions it aims to answer are:
* Does installing an air purifier in the homes of children and young people with asthma improve their asthma outcomes (including reduction in asthma exacerbations, improvement in symptom control, improvement in quality of life).
* Is the use of an air purifier in the home acceptable to children and young people and their families?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Installation of air purifier (Rensair Ltd - Rensair Compact)
Rensair Compact air purifier unit will be installed in the homes of all children/young people participating in this study for a period of one-year.
Rensair Compact air purifier unit
Installation of Rensair Compact air purifier (Rensair Ltd.) in the homes of children/young people participating in this study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rensair Compact air purifier unit
Installation of Rensair Compact air purifier (Rensair Ltd.) in the homes of children/young people participating in this study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attend the asthma clinic in our hospital
* Have a confirmed physician-diagnosis of asthma from the asthma clinic
* Live in mainland England (this is due to delivery of the air purification units and also associated maintenance of them)
5 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liverpool
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
karl A Holden
Role: PRINCIPAL_INVESTIGATOR
University of Liverpool
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alder Hey Children's Hospital
Liverpool, Merseyside, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UoL001754
Identifier Type: -
Identifier Source: org_study_id